Icares Medicus Inc (6612)

Currency in TWD
73.80
+2.20(+3.07%)
Closed·
Earnings results expected tomorrow
6612 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
72.6074.80
52 wk Range
66.00110.50
Key Statistics
Bid/Ask
62.40 / 62.90
Prev. Close
128
Open
72.8
Day's Range
72.6-74.8
52 wk Range
66-110.5
Volume
25.14K
Average Volume (3m)
43.02K
1-Year Change
-25.5229%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6612 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
May 14, 2026
EPS / Forecast
0.81 / --
Revenue / Forecast
298.62M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.89%
Dividend Yield
0.23%
Industry Median 4.02%
Annualised payout
0.30
Paid annually
5-Years Growth
+29.43%
Growth Streak

6612 Income Statement

Compare 6612 to Peers and Sector

Metrics to compare
6612
Peers
Sector
Relationship
P/E Ratio
82.8x19.2x−0.4x
PEG Ratio
−1.232.180.00
Price/Book
1.9x1.3x2.6x
Price / LTM Sales
3.1x1.1x3.1x
Upside (Analyst Target)
-11.9%48.8%
Fair Value Upside
Unlock35.1%5.7%Unlock

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and lubricious implantable and invasive high-end nanomedicine material. Further, the company engages in molding, mold design, and development; production of medical devices and electronic plastic products; and distribution of ophthalmic medical equipment. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
125.90K0.27%9.29M
Other Institutional Investors
14.15M29.89%1.04B
Public Companies & Retail Investors
33.06M69.84%2.44B
Total
47.34M100.00%3.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Loh Trust Holdings LLC15.44%7,311,392539,581
San Yang Metal Industrial Co., Ltd4.09%1,936,287142,898

FAQ

What Is the Icares Medicus (6612) Stock Price Today?

The Icares Medicus stock price today is 73.80 TWD.

What Stock Exchange Does Icares Medicus Trade On?

Icares Medicus is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Icares Medicus?

The stock symbol for Icares Medicus is "6612."

What Is the Icares Medicus Market Cap?

As of today, Icares Medicus market cap is 3.49B TWD.

What Is Icares Medicus's Earnings Per Share (TTM)?

The Icares Medicus EPS (TTM) is 0.89.

When Is the Next Icares Medicus Earnings Date?

Icares Medicus will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is 6612 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Icares Medicus Stock Split?

Icares Medicus has split 2 times.

What is the current trading status of Icares Medicus (6612)?

As of Aug 09, 2026, Icares Medicus (6612) is trading at a price of 73.80 TWD, with a previous close of 128.00 TWD. The stock has fluctuated within a day range of 72.60 TWD to 74.80 TWD, while its 52-week range spans from 66.00 TWD to 110.50 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.